To further our understanding of the role of EGFR signaling during virus infection, we performed a time-of-addition assay, and found that post-entry stages were also affected by the EGFR-specific inhibitor Gefitinib during infection of A549 cells (Figure 3). Here, EGFR is linked to viral infectious disease.